CardioDynamics BioZ(R) ICG Technology Integrates with General Electric Healthcare's Centricity(R) Electronic Medical Record (EMR
05 Agosto 2008 - 10:00AM
PR Newswire (US)
GE Centricity(R) -- Third Largest U.S. Outpatient EMR with Nearly
10% Market Share SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ --
CardioDynamics (NASDAQ:CDIC), the innovator and leader of BioZ(R)
impedance cardiography (ICG) technology, today announced that the
Company's BioZ(R) Dx now seamlessly integrates with General
Electric Healthcare's Centricity(R) electronic medical record (EMR)
system. The Company released this week its latest version of
BioZport(R) ICG data management software which includes
capabilities to automatically integrate and transfer BioZ(R) ICG
data from the BioZ(R) Dx to GE Healthcare's Centricity(R) EMR
system. This is a strategic advancement for the Company's flagship
product as EMR interface and paperless workflow are increasingly
becoming necessities to the outpatient physician when making
decisions on new medical technologies. Currently, it is estimated
that 24% of U.S. outpatient physicians utilize an EMR system.
Medical device to EMR interface capability will continue to grow in
importance as U.S. outpatient-based physician use of EMR is
forecasted to grow at over 16% per year through 2013. Michael K.
Perry, CardioDynamics Chief Executive Officer, stated, "We are
extremely pleased to release our initial BioZ ICG direct EMR
interface. EMR is a driving, essential factor in the majority of
medical device decisions for early adopter physicians and large
physician practices. Interfacing with our long-time partner, GE
Healthcare, whose Centricity(R) system has nearly 10% share in our
sizable outpatient physician market, is a great accomplishment for
our company, customers, prospective customers and investors." Perry
continued, "Our EMR strategy is to partner with the top 10% to 15%
of EMR suppliers, who collectively have 80% of U.S. outpatient
market share. Allscripts, the second largest outpatient EMR
provider, with over 12% market share, is our next planned
interface. With increasing penetration rates for both ICG and EMR,
interface capability should further accelerate the adoption of ICG
and supports our long-term vision that BioZ ICG is present in every
physician office that prescribes cardiovascular medicine for heart
failure, shortness of breath and high blood pressure patients."
BioZ ICG technology presently resides in approximately one out of
every six (16%) cardiology offices as well as one out of every five
(20%) outpatient heart failure clinics in the United States with
over one million BioZ tests performed annually. For further
information, please contact Emma Brejwo at . About CardioDynamics:
CardioDynamics (NASDAQ:CDIC), the ICG Company, is the innovator and
leader of an important medical technology called BioZ(R) Impedance
Cardiography (ICG). The Company develops, manufactures and markets
noninvasive BioZ(R) ICG products and medical device electrodes. The
Company's BioZ(R) ICG Systems are being used by physicians around
the world to help battle the number one killer of men and women --
cardiovascular disease. Partners include GE Healthcare, Philips
Medical Systems, and Mindray. For additional information, please
refer to the company's Web site at http://www.cdic.com/.
Forward-Looking (Safe Harbor) Statement: Except for the historical
and factual information contained herein, this press release
contains forward-looking statements, the accuracy of which is
necessarily subject to uncertainties and risks including the
Company's sole dependence on the BioZ(R) product line, and various
uncertainties characteristic of early growth companies, as well as
other risks detailed in the Company's filings with the SEC,
including its 2007 Form 10-K. The Company does not undertake to
update the disclosures contained in this press release. DATASOURCE:
CardioDynamics CONTACT: Emma Brejwo, Investor Relations Associate
of CardioDynamics, 1-800-778-4825, Ext. 1031, Web site:
http://www.cdic.com/
Copyright
Cardiodynamics International (MM) (NASDAQ:CDIC)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Cardiodynamics International (MM) (NASDAQ:CDIC)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024
Notícias em tempo-real sobre Cardiodynamics International (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Cardiodynamics International (MM)